Guidelines ACR Clinical GuidelinesAxial Spondyloarthritis2019 Axial SpA Guidelines 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis Documents related to 2019 guideline: Axial SpA Guideline Appendix 1 – Methods Axial SpA Guideline Appendix 2 – Panel/Teams Involved Axial SpA Guideline Appendix 3 – Outcomes Framework Axial SpA Guideline Appendix 4 – Search Strategies Axial SpA Guideline Appendix 5 – Study Selection Process Axial SpA Guideline Appendix 6 – Evidence Report Axial SpA Guideline Disclosure Summary Project Plan Glucocorticoid-Induced Osteoporosis2017 GIOP Guideline 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis Documents related to 2019 guideline: Appendix 1 – Methods Appendix 2 – Panel/Teams Involved Appendix 3 – Evidence Report Appendix 4 – Search Strategies Appendix 5 – Study Selection Process Disclosure Summary of ACR Committee Reviewers Project Plan Public Comments Author Response to Public Comments Gout2020 Gout Guideline 2020 American College of Rheumatology Guideline for the Management of Gout Documents related to this guideline: Gout Guideline Supplementary Appendix 1 – Methods Gout Guideline Supplementary Appendix 2 – Panel/Teams Involved Gout Guideline Supplementary Appendix 3 – Specification of Important and Critical Outcomes Identified for the Systematic Literature Review Gout Guideline Supplementary Appendix 4 – Search Strategies Gout Guideline Supplementary Appendix 5 – Study Selection Process Gout Guideline Supplementary Appendix 6 – Network Meta-Analyses to Support Decision-Making Regarding Use of ULT Gout Guideline Supplementary Appendix 7 – Network Meta-Analyses to Support Decision-Making Regarding Use of Anti-Inflammatory Agents Gout Guideline Supplementary Appendix 8 – Evidence Report/Summary of Findings Tables Gout Guideline Supplementary Appendix 9 – Medication Costs Gout Guideline Supplementary Appendix 10 – Supplementary Figures Gout Guideline Disclosure Summary Gout Guideline Project Plan Juvenile Idiopathic Arthritis2021 JIA Guidelines ACR Juvenile Idiopathic Arthritis Guideline Project Plan ACR Juvenile Idiopathic Arthritis Public Comments ACR Juvenile Idiopathic Arthritis Guideline Author Response to Public Comments Lyme Disease2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease (final publication of guideline anticipated in early summer 2020)Osteoarthritis2019 Osteoarthritis Guideline American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee - 2019 Documents related to the 2019 Osteoarthritis Guideline: Osteoarthritis Guideline Appendix 1 – Methods Osteoarthritis Guideline Appendix 2 – Evidence Report Osteoarthritis Guideline Appendix 3 – Panel/Teams Involved Osteoarthritis Guideline Appendix 4 – Search Strategies Osteoarthritis Guideline Appendix 5 – Study Selection Process Osteoarthritis Guideline Disclosure Summary ACR Osteoarthritis Guideline Project Plan Perioperative Management 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty Documents related to this guideline: Appendix 1 – Methods Appendix 2 – Panel/Teams Involved Appendix 3 – PICO Questions Appendix 4 – Search Strategies Appendix 5 – Study Selection Process Disclosure Summary of ACR Committee Reviewers Clinical Practice Guidelines: Incorporating Input From a Patient Panel Perioperative Management Project Plan Public Comments Gout2020 Gout Guideline 2020 American College of Rheumatology Guideline for the Management of Gout Documents related to this guideline: Gout Guideline Supplementary Appendix 1 – Methods Gout Guideline Supplementary Appendix 2 – Panel/Teams Involved Gout Guideline Supplementary Appendix 3 – Specification of Important and Critical Outcomes Identified for the Systematic Literature Review Gout Guideline Supplementary Appendix 4 – Search Strategies Gout Guideline Supplementary Appendix 5 – Study Selection Process Gout Guideline Supplementary Appendix 6 – Network Meta-Analyses to Support Decision-Making Regarding Use of ULT Gout Guideline Supplementary Appendix 7 – Network Meta-Analyses to Support Decision-Making Regarding Use of Anti-Inflammatory Agents Gout Guideline Supplementary Appendix 8 – Evidence Report/Summary of Findings Tables Gout Guideline Supplementary Appendix 9 – Medication Costs Gout Guideline Supplementary Appendix 10 – Supplementary Figures Gout Guideline Disclosure Summary Gout Guideline Project Plan Gout2020 Gout Guideline 2020 American College of Rheumatology Guideline for the Management of Gout Documents related to this guideline: Gout Guideline Supplementary Appendix 1 – Methods Gout Guideline Supplementary Appendix 2 – Panel/Teams Involved Gout Guideline Supplementary Appendix 3 – Specification of Important and Critical Outcomes Identified for the Systematic Literature Review Gout Guideline Supplementary Appendix 4 – Search Strategies Gout Guideline Supplementary Appendix 5 – Study Selection Process Gout Guideline Supplementary Appendix 6 – Network Meta-Analyses to Support Decision-Making Regarding Use of ULT Gout Guideline Supplementary Appendix 7 – Network Meta-Analyses to Support Decision-Making Regarding Use of Anti-Inflammatory Agents Gout Guideline Supplementary Appendix 8 – Evidence Report/Summary of Findings Tables Gout Guideline Supplementary Appendix 9 – Medication Costs Gout Guideline Supplementary Appendix 10 – Supplementary Figures Gout Guideline Disclosure Summary Gout Guideline Project Plan Gout2020 Gout Guideline 2020 American College of Rheumatology Guideline for the Management of Gout Documents related to this guideline: Gout Guideline Supplementary Appendix 1 – Methods Gout Guideline Supplementary Appendix 2 – Panel/Teams Involved Gout Guideline Supplementary Appendix 3 – Specification of Important and Critical Outcomes Identified for the Systematic Literature Review Gout Guideline Supplementary Appendix 4 – Search Strategies Gout Guideline Supplementary Appendix 5 – Study Selection Process Gout Guideline Supplementary Appendix 6 – Network Meta-Analyses to Support Decision-Making Regarding Use of ULT Gout Guideline Supplementary Appendix 7 – Network Meta-Analyses to Support Decision-Making Regarding Use of Anti-Inflammatory Agents Gout Guideline Supplementary Appendix 8 – Evidence Report/Summary of Findings Tables Gout Guideline Supplementary Appendix 9 – Medication Costs Gout Guideline Supplementary Appendix 10 – Supplementary Figures Gout Guideline Disclosure Summary Gout Guideline Project Plan Gout2020 Gout Guideline 2020 American College of Rheumatology Guideline for the Management of Gout Documents related to this guideline: Gout Guideline Supplementary Appendix 1 – Methods Gout Guideline Supplementary Appendix 2 – Panel/Teams Involved Gout Guideline Supplementary Appendix 3 – Specification of Important and Critical Outcomes Identified for the Systematic Literature Review Gout Guideline Supplementary Appendix 4 – Search Strategies Gout Guideline Supplementary Appendix 5 – Study Selection Process Gout Guideline Supplementary Appendix 6 – Network Meta-Analyses to Support Decision-Making Regarding Use of ULT Gout Guideline Supplementary Appendix 7 – Network Meta-Analyses to Support Decision-Making Regarding Use of Anti-Inflammatory Agents Gout Guideline Supplementary Appendix 8 – Evidence Report/Summary of Findings Tables Gout Guideline Supplementary Appendix 9 – Medication Costs Gout Guideline Supplementary Appendix 10 – Supplementary Figures Gout Guideline Disclosure Summary Gout Guideline Project Plan
